Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BMP Sunstone has received an import drug license from the SFDA to market a new Propess applicator in China.
Subscribe to our email newsletter
The import drug license (IDL) approved will enable BMP Sunstone to market and distribute Propess vaginal inserts that are 0.8mm thick.
BMP’s Propess applicator improves efficacy and broadens the potential use of Propess to women with premature rupture of membranes (PROM). The company estimates that the 0.8mm Propess will increase the number of targeted women with Prom by approximately 500,000, or 3% of all pregnant women in China.
Cytokine PharmaScience, the licensor, is in the process of applying for a new brand name for the 0.8mm insert. Propess has been adopted as the first line treatment by China OB association. The company anticipates distributing the 0.8mm Propess by September 2008.
David Gao, CEO of BMP Sunstone, said: “We anticipate that the 0.8mm Propess will help us to expand our distribution network to 1000 hospitals by 2010, and cover more than 1.5 million pregnant women per year.”